Underlying comorbidities in Covid-19 related deaths by age group in Colombia

Comorbilidades de los fallecidos por COVID-19 según el grupo etario en Colombia

Introduction: The emerging COVID-19 pandemic caused by the SARS-CoV-2 virus represents a global health crisis which causes serious illness and death, predominantly in patients with underlying cardiovascular and metabolic anomalies. Objective: to conduct a statistical analysis of the underlying comorbidities in patients who died from COVID-19 and its distribution by age group in Colombia. Methodology: we worked on two research hypotheses. A one-factor ANOVA test was applied for the hypotheses and analyzed in the SPSS v 25.0 statistical package. Results: the significance level was 0.000, which is less than α= 0.05, therefore, the hypothesis (Ha) was accepted, which means there are differences in the average scores obtained in COVID-19-related deaths for a specific comorbidity and its distribution by age group in Colombia. Conclusion: It was determined that the most frequent comorbidity was HT (hypertension) in 5.861 cases and the most vulnerable group was the 70-79 age group; the following underlying comorbidity was DM (diabetes mellitus) in 3.589 cases, the 60-69 age group being the most vulnerable; and respiratory diseases in 2.280 cases.

1. Tay MZ, Poh CM, Renia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;20(6):363-74. doi: 10.1038/s41577-020-0311-8
2. Velavan TP, Meyer CG. The COVID-19 epidemic. Trop Med Int Health. 2020;25(3):278-80. doi: 10.1111/tmi.13383
3. Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):271-80 e8. doi: 10.1016/j.cell.2020.02.052
4. Fignani D, Licata G, Brusco N, Nigi L, Grieco GE, Marselli L, et al. SARS-CoV-2 receptor Angiotensin I-Converting Enzyme type 2 (ACE2) is expressed in human pancreatic β-cells and in the human pancreas microvasculature. bioRxiv. 2020:2020.07.23.208041. doi: 10.1101/2020.07.23.208041
5. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13. doi: 10.1016/S0140-6736(20)30211-7
6. Sardu C, D'Onofrio N, Balestrieri ML, Barbieri M, Rizzo MR, Messina V, et al. Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control? Diabetes care. 2020;43(7):1408-15. doi: 10.2337/dc20-0723
7. Sardu C, D'Onofrio N, Balestrieri ML, Barbieri M, Rizzo MR, Messina V, et al. Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control? Diabetes care. 2020;43(7):1408-15. doi: 10.2337/dc20-0723
8. Wu J, Huang J, Zhu G, Wang Q, Lv Q, Huang Y, et al. Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study. BMJ Open Diabetes Res Care. 2020;8(1). doi: 10.1136/bmjdrc-2020-001476
9. Chee YJ, Ng SJH, Yeoh E. Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus. Diabetes Res Clin Pract. 2020;164:108166. doi: 10.1016/j.diabres.2020.108166
10. Organización Panamericana de la Salud, Organización Mundial de la Salud. COVID-19 y comorbilidades - AMÉRICAS. Organización Mundial de la Salud; 2020. p. 2.
11. Kamps BS, Hoffman C. Comorbilidades [Internet]. Steinhauser Verlag; 2020 [citado 2020 octubre]; Disponible en: https://covidreference.com/comorbs_es.
12. Díaz-Pinzón, J.E. Estimación de las tasas de mortalidad y letalidad por COVID-19 en Colombia. Repert Med Cir. 2020;29(Supl. Núm. 1):89-93. doi: 10.31260/RepertMedCir.01217372.1103
13. Díaz-Pinzón JE. Simulador Applet Descartes: Como didáctica de enseñanza de la función cuadrática. INNOVA Research Journal 2017;2(8):69-78. doi: 10.33890/innova. V2. N8.2017.256
14. Instituto Nacional de Salud. Coronavirus (COVID-2019) en Colombia [Internet]. Bogotá: Instituto Nacional de Salud; 2020. [citado 2020 octubre 28]; Recuperado de: https://www.ins.gov.co/Noticias/Paginas/Coronavirus.aspx.
15. Díaz-Pinzón JE. Precisión del pronóstico de la propagación del COVID-19 en Colombia. Repert Med Cir. 2020;29(Núm.Supl.1):27-33. doi: 10.31260/RepertMedCir.01217372.1045